News - 19 Nov 2010
In the past 40 years, scientists have learned a great deal about how cells become cancerous. Some of that knowledge has translated to new treatments, but most of the time doctors are forced to rely on...
News - 22 Mar 2010
Arrowhead Research Corporation (NASDAQ: ARWR) today announced that the clinical trial being conducted by majority-owned subsidiary, Calando Pharmaceuticals, Inc. has demonstrated systemic delivery of...
News - 10 Feb 2009
Research and Markets has announced the addition of Jain PharmaBiotech's new report "RNAi - Technologies, Markets and Companies" to their offering.
RNA interference (RNAi) or gene...
News - 24 May 2013
Reportlinker.com announces that a new market research report is available in its catalogue: Proteomics: Technologies and Global Markets
STUDY GOALS AND OBJECTIVES
BCC Research's goal for...
News - 13 Feb 2013
Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced today its key product development, corporate, and partner milestones for...
News - 8 Nov 2010
A $16-million, five-year grant by the National Cancer Institute’s nanomedicine initiative blends the expertise of five research institutions to focus an array of innovative nanotechnologies on...
Article - 8 Nov 2007
In this article, conductivity of intrinsic guanine rich sequences of λ-DNA was found to be length dependent. These results provide insights into the electrical behavior of guanine rich sequences...
Article - 14 May 2007
This paper explores the types and structures of nanoparticles used in cancer treatment, nano-based drug delivery systems,.